Sturge-Weber syndrome is a rare, sporadic, neurocutaneous disorder classically characterized by a facial nevus in the trigeminal distribution (port wine stain), leptomeningeal angiomatosis, and glaucoma, although intracranial changes can be present without cutaneous involvement.1 Seizures occur in up to 75% of individuals, are often associated with headache, and stroke-like episodes causing prolonged neurologic deficits are also described.1,2
Headache meeting criteria for migraine attack in association with electrographic status epilepticus has previously been reported as status epilepticus migrainosus.3 We report clinical, electrophysiologic, and functional imaging findings in a patient with occipital Sturge-Weber syndrome without facial nevus during a prolonged episode of headache, visual field deficit, and focal occipital status epilepticus.
Case report.
An 18-year-old intellectually normal man with a history of focal seizures and episodes of nonconvulsive status epilepticus was admitted to our epilepsy monitoring unit for characterization and consideration for surgery. He was born at term after an uneventful pregnancy and had normal early childhood development. Seizures started at age 2 years and comprised flashing lights in the right visual field, right arm clonic movements, tinnitus, and postictal dysphasia. Seizures lasted up to 20 minutes, and were often accompanied by severe throbbing global headache that persisted for hours to days. There was no history of headache unrelated to seizures. Neuroimaging was typical of Sturge-Weber syndrome (figure, A–C) and baseline fluorodeoxyglucose (FDG) PET showed hypometabolism over the left occipital cortex (figure, E). Visual fields were normal on perimetry.
Figure. Structural imaging, EEG, and ictal vs interictal findings on functional imaging (PET and SPECT).
(A) CT shows intraparenchymal calcifications in the left occipital region. (B) Susceptibility-weighted MRI shows abnormal vasculature (arrowhead) and areas of signal loss over the left occipital region (arrow). (C) T1-weighted postcontrast image shows leptomeningeal enhancement, volume loss over the left occipital pole (black arrowhead), and an enlarged choroid plexus on the left (white arrowhead). (D) Five-second EEG epochs show focal spikes and rhythmic slowing over the left occipital region during a focal seizure (top panel) and polymorphic delta slowing over the left posterior quadrant without epileptiform discharges during the prolonged “ictal” period (bottom panel). (E) Interictal (left) and ictal (right) FDG-PET axial views show hypometabolism of the left occipital cortex during the interictal period (arrow) and hypermetabolism (arrowhead) during the prolonged “ictal” state. (F) Interictal (left) and ictal (right) SPECT axial views show relative hypoperfusion of the left occipital cortex during the ictal state (arrowheads).
At admission, EEG showed normal background rhythms and infrequent left occipital spike-wave epileptiform discharges. After gradual withdrawal of routine medications (topiramate, levetiracetam, and lamotrigine) over 72 hours, frequent focal seizures occurred. Episodes of flashing lights with distorted vision in the patient’s right visual field were reported and these were inconsistently associated with focal spiking and evolving theta rhythms over the left occipital region (figure, D). Technitium-99m ethyl cysteinate dimer was injected during a clinical seizure followed by a SPECT scan, and this revealed ictal hypoperfusion over left occipital cortex (figure, F).
Over the next 24 hours, the patient developed a severe throbbing headache lateralized to the left side, nausea requiring antiemetic medications, a right visual field defect on bedside confrontation testing, and continued reporting of intermittent flashing lights in the right visual field. During this period, the EEG showed persistent left occipital polymorphic delta slowing without epileptiform discharges (figure, D). Due to uncertainty whether the persistent symptoms were migrainous or epileptic, an FDG-PET scan was obtained, which showed remarkable hypermetabolism over the left occipital region compared to baseline (figure, F).
The patient was treated for status epilepticus with IV benzodiazepines and his usual antiepileptic medications were recommenced. IV chlorpromazine was administered for treatment of “migraine” headache. There was resolution of headache and visual field deficits over the next 24 hours and EEG returned to baseline.
Discussion.
The etiology of Sturge-Weber syndrome is not known but it is suggested that there is failure of regression of primitive cephalic venous plexus affecting the ectoderm destined to become the upper facial skin and scalp as well as the parieto-occipital area of the brain.2 Somatic mosaic mutations have long been suspected as the likely cause, and recently, mutations in the GNAQ gene have been found in affected brain and skin tissue.4 Whether headaches are a consequence of the epileptic activity or due to shared underlying pathology in the trigeminovascular system remains a mystery. Children with Sturge-Weber syndrome show functional imaging abnormalities that evolve over time. SPECT and PET studies in infants demonstrate interictal hyperperfusion and hypermetabolism, which changes to interictal hypoperfusion of the involved cortex after infancy.5,6 Increased metabolic demand during epileptic activity in the presence of reduced perfusion, i.e., abnormal neurovascular coupling, is presumed to contribute to neuronal injury during prolonged seizures in childhood, although this has not been demonstrated directly.2,6 Evidence of such altered neurovascular coupling has also been found during invasive monitoring in patients with aneurysmal subarachnoid haemorrhage and likely contributes to neuronal injury.7
Our patient with Sturge-Weber syndrome concurrently developed focal occipital status epilepticus and a prolonged headache that met criteria for migraine headache attack.8 PET showed markedly increased cortical metabolism consistent with ongoing epileptic activity, whereas ictal SPECT showed reduced perfusion of the involved cortical region. This provides neuroimaging evidence for abnormal neurovascular coupling in an adult with Sturge-Weber syndrome during status epilepticus migrainosus. From a clinical perspective, this case also highlights the role of functional imaging in determining the underlying etiology of a patient's symptoms as epileptic in the absence of scalp EEG discharges, thus guiding appropriate treatment.
Footnotes
Author contributions: Moksh Sethi: study concept and design, writing and revision of the manuscript, figure, and legend. Magdalena Kowalczyk: study concept and design, writing and revision of the manuscript and figure. Linda Dalic: revision of the manuscript, figure, and legend for intellectual content. John S. Archer: revision the manuscript, figure, and legend for intellectual content. Graeme D. Jackson: study concept and design, revision of the manuscript, figure, and legend for intellectual content.
Study funding: No targeted funding reported.
Disclosure: The authors report no disclosures relevant to the manuscript. Go to Neurology.org for full disclosures.
References
- 1.Comi AM. Presentation, diagnosis, pathophysiology and treatment of the neurologic features of Sturge-Weber syndrome. Neurologist 2011;17:179. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Comi AM. Topical review: pathophysiology of Sturge-Weber syndrome. J Child Neurol 2003;18:509–516. [DOI] [PubMed] [Google Scholar]
- 3.Striano P, Belcastro V, Parisi P, Perucca P, Terzaghi M, Manni R. Status epilepticus migrainosus: clinical, electrophysiologic, and imaging characteristics. Neurology 2011;76:761. [DOI] [PubMed] [Google Scholar]
- 4.Chugani HT, Mazziotta JC, Phelps ME. Sturge-Weber syndrome: a study of cerebral glucose utilization with positron emission tomography. J Pediatr 1989;114:244–253. [DOI] [PubMed] [Google Scholar]
- 5.Pinton F, Chiron C, Enjolras O, Motte J, Syrota A, Dulac O. Early single photon emission computed tomography in Sturge-Weber syndrome. J Neurol Neurosurg Psychiatry 1997;63:616–621. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6.Dreier JP, Major S, Manning A, et al. Cortical spreading ischaemia is a novel process involved in ischaemic damage in patients with aneurysmal subarachnoid haemorrhage. Brain 2009;132:1866–1881. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, beta version. Cephalalgia 2013;33:629–808. [DOI] [PubMed] [Google Scholar]
- 8.Shirley MD, Tang H, Gallione CJ, et al. Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ. N Engl J Med 2013;368:1971–1979. [DOI] [PMC free article] [PubMed] [Google Scholar]

